Company intelligence / Profile preview

Agrivida

Village of Four Seasons, Missouri, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Agrivida’s primary product, GRAINZYME Phytase, received USDA and FDA approvals for commercial animal feed use, showing improved poultry and swine performance and enhanced sustainability over traditional phytase supplementation.

Therapeutic areas: Other
Modalities: Protein (enzyme)
Industry: Agriculture & AgTech

Partnerships

Kerry Animal Health & Nutrition (AlphaGal NSP enzyme distribution partnership)

Beyond the preview

Go deeper on Agrivida.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agrivida.

Explore the full profile